HR positive, HER2 negative breast cancer

Details

Files
Project Status:
Complete
Therapeutic Area:
HR positive, HER2 negative breast cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0041-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted : February 29, 2024
Stakeholder Feedback Deadline: March 07,2024
Final Report Posted: April 10, 2024